Legal Representation
Attorney
Andrew N. Spivak
USPTO Deadlines
Next Deadline
975 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2008-03-11)
Due Date
March 11, 2028
Grace Period Ends
September 11, 2028
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 27, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Jul 27, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jul 27, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jul 27, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jul 27, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Oct 23, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Aug 8, 2018 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Aug 6, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Aug 6, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Mar 22, 2018 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Mar 22, 2018 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Mar 22, 2018 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| Mar 21, 2018 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Mar 8, 2018 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
| Mar 11, 2017 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Mar 23, 2016 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Sep 8, 2014 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Sep 8, 2014 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Sep 8, 2014 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Aug 22, 2014 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
| May 20, 2008 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| May 20, 2008 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Mar 11, 2008 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Feb 3, 2008 | ALIE | A | ASSIGNED TO LIE |
| Feb 3, 2008 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED |
| Dec 22, 2007 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Dec 19, 2007 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Nov 29, 2007 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Nov 29, 2007 | IUAF | S | USE AMENDMENT FILED |
| Jun 20, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 20, 2007 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jun 20, 2007 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jan 10, 2007 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Jan 10, 2007 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Jan 10, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 10, 2007 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jan 10, 2007 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jul 11, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 18, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 29, 2006 | NPUB | O | NOTICE OF PUBLICATION |
| Mar 1, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Feb 24, 2006 | ALIE | A | ASSIGNED TO LIE |
| Feb 22, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 21, 2006 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 14, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 14, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Dec 19, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Dec 19, 2005 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Dec 13, 2005 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 29, 2005 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF OBESITY, INDUCEMENT OF WEIGHT LOSS, AND PREVENTION OF WEIGHT GAIN
First Use Anywhere:
Oct 2, 2007
First Use in Commerce:
Oct 2, 2007
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"OREXIGEN"